Biopharma
Advancing the discovery, development, and delivery of next-generation therapies
Explore how Mayo Clinic Platform helps biopharma harness real-world data, leverage advanced AI, and collaborate with world-class research to strengthen and progress clinical development.
On this page

Mayo Clinic Platform_
Orchestrate
Enhancing biopharma innovation with the real-world data, AI capabilities, and scientific expertise needed to drive discovery and advance transformative therapies.
Mayo Clinic Platform_Orchestrate offers a single point of engagement for biopharma to access Mayo Clinic’s rich real-world data, advanced analytics, core lab services, and research expertise.
By integrating these capabilities into a secure, streamlined ecosystem, Orchestrate helps partners expedite clinical development, validate clinically meaningful AI, and unlock translational insights that strengthen R&D programs from concept to completion.
Join us
Advantages of partnering with Mayo Clinic Platform
Accelerate biopharma discovery with trusted clinical data, AI-powered analytics, and scientific collaboration.

Integrated data, AI, and scientific expertise in one ecosystem
Mayo Clinic Platform unifies real-world data, advanced analytics, AI capabilities, and world-class scientific insight, giving biopharma a single environment to accelerate discovery and strengthen clinical development.
Access to rich, diverse, and high-fidelity real-world data
Biopharma companies can securely analyze de-identified clinical data spanning rare, complex, and diverse patient populations to generate evidence, uncover insights, and inform more equitable therapies.
Support from concept through clinical impact
From early exploration and study design to algorithm validation and evidence generation, Mayo Clinic Platform provides structured processes, technical onboarding, and program management to advance R&D programs efficiently.
Collaborative research with world-class clinicians and scientists
Biopharma partners benefit from direct engagement with Mayo Clinic experts, including access to biospecimens, multi-omics profiling, and translational research capabilities that drive deeper understanding and innovation.